Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcers Forward Looking Statements This press release includes "forward-looking statements" (as defined under Federal securities laws). All statements other than statements of historical facts are "forward-looking statements," including those relating to future events. In some cases, you can identify forward-looking statements by terminology such as " ...